Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology Supplements
Published in: Clinical Research in Cardiology Supplements 1/2012

Open Access 01-06-2012

Editorial

Author: Prof. Dr. med. D. Horstkotte

Published in: Clinical Research in Cardiology Supplements | Special Issue 1/2012

Login to get access

Excerpt

Elevated LDL-cholesterol and/or disproportional LDL/HDL serum concentrations are accepted to significantly increase cardiovascular complications. The impact of lipoprotein antigen (Lp(a)) to accelerate arteriosclerosis and consequent complications is yet less investigated but up-to-date scientific work indicates its important role in the manifestation of adverse cardiovascular events. Lp(a) serum concentrations can only moderately be lowered by lifestyle modification or drugs. …
Metadata
Title
Editorial
Author
Prof. Dr. med. D. Horstkotte
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Clinical Research in Cardiology Supplements / Issue Special Issue 1/2012
Print ISSN: 1861-0706
Electronic ISSN: 1861-0714
DOI
https://doi.org/10.1007/s11789-012-0050-x

Other articles of this Special Issue 1/2012

Clinical Research in Cardiology Supplements 1/2012 Go to the issue

OriginalPaper

Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis

OriginalPaper

Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R)

OriginalPaper

Lipid apheresis techniques: current status in Germany

OriginalPaper

Lipid apheresis: oxidative stress, rheology, and vasodilatation

OriginalPaper

Fibrinogen/LDL apheresis is a promising rescue therapy for sudden sensorineural hearing loss

OriginalPaper

Role of lipid apheresis in changing times

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits